Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by okgonowon Mar 31, 2024 10:24pm
191 Views
Post# 35962117

first time on

first time on since Friday .....

i like the enthusiasm of some posters on here ...nice to see but lets keep it just a little real for now!
hey i think I have a winner on my hands as well (or at least very optemistic) on wher LABS is heading but lets just slow the roll a tad ....like in the movie you start with "Baby steps" before you go to full stride all out 100meter dash strides.

I think Sub1i may have gone off his meds hence all the posts on Saturday continuing today and with predictions of ..what was it $40 per share. quantaty does not = quality.! you dont go Trapshooting with a machinegun do you?

I think i was the first one to post how excellent the Drobinol numbers were just under $100k for the whole year 2023 and $1.5 mill in delivery and orders in first Q ... the thing we dont know is whats the profit margins for MPL on that skew. so i have to tame my exitement just a bit till we find out.

Also Pidduck's mention of how he feels SP is undervalued ...in the sentence after that he said something about it should be $.15 ... please correct me if im wrong.

yes many positive things happening all at once here for this little company and possible renewed interest in the Pot sector..we have a good one with MPL money in the bank,next to no debt
 
the reality today is we had a rise to our 52 week high for a split second but then pulled back to $.08 we couldnt stay or surpass even with the perfect timing on Q4 and 2023 numbers and such a positive CC

the volume was up but nothing like some of the other pot stocks which traded 10's of millions of shares 

very few know the MPL story and i hope Pidduck and team start to spred the word

if we stay below .$.10 this week i will at least double my position if we start to move above $.10 i will average up at the right time when i see a sustained up pattern form.

for now i woud be happy with a rise to $.40 in the next 3 months and then up from there possibly $.80 to $1 by year end if Germany becoms the cash Cow and something happens with reschedouling in the US.

GLTA
<< Previous
Bullboard Posts
Next >>